Please login to the form below

Not currently logged in
Email:
Password:

Mysimba

This page shows the latest Mysimba news and features for those working in and with pharma, biotech and healthcare.

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study

None of these has made significant headway since their US launches, and of the three only Orexigen's drug (branded as  Mysimba) has been backed in Europe, with both Belviq and

Latest news

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    s drug under the Mysimba brand name last December. ... The latest development means European doctors could have three drugs at their disposal to manage obesity patients in the coming months, with Saxenda and Mysimba slotting into the market alongside

  • Orexigen’s obesity pill Mysimba set for European approval Orexigen’s obesity pill Mysimba set for European approval

    The CHMP has recommended a marketing authorisation for Mysimba (naltrexone/bupropion) for weight management of overweight or obese adults. ... Across these studies, more patients treated with Mysimba achieved clinically-relevant weight loss than patients

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics